Case Time! VTE Prophylaxis Post Hip Replacement
Victor F. Tapson, MD
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
Scott Kaatz, DO, MSc, FACP, SFHM
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
Deborah Siegal, MD, MSc, FRCPC
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Case Study - New Guideline Recommendations into Clinical Practice for the Patient with AF
Manesh R. Patel, MD
Impact of Social Determinants of Health on Management of AF
Kevin Thomas, MD
What Are the 10 Key Takeaways for the 2023 ACC/AHA/ACCP/HRS Guideline for AF?
ACC/AHA/ACCP/HRS Guideline Updates in the Management of Atrial Fibrillation
Sean Pokorney, MD
Mina K. Chung, MD
How Do We Best Incorporate Latest Guidance in Optimizing Care for the Patient with AF?
What Are the Latest Updates on the Clinical and Economic Impact of AF?
Anticoagulation Management of AF: What Has Changed?
AF Screening, Risk Factors, and Diagnosis: What’s New?
Latest Guidance on Anticoagulation in Special AF Patient Populations
Cardiovascular Disease in T2D: Researchers Identify Potential Therapeutic Target for Underlying Cause
New Guidance on Neurodevelopment Outcomes in Patients with Heart Defects
Loading...
NEW FEATURES:
Tell us what you think by using our Feedback button
We’re glad to see you’re enjoying Global Cardiology Academy… but how about a more personalized experience?
Press cancel to remain on Global Cardiology Academy. Press the link below or the continue button to keep going.